[{"symbol": "PFE", "publishedDate": "2019-08-22 10:20:00", "title": "Pfizer's Xtandi Label Expansion Filing Gets Priority Review", "image": "https://cdn.snapi.dev/images/v1/b/g/drugs24.jpg", "site": "Zacks Investment Research", "text": "If data from ARCHES study is approved to be included in the label of Pfizer's (PFE) Xtandi, it can treat a broader prostate cancer patient population.", "url": "https://www.zacks.com/stock/news/482846/pfizers-xtandi-label-expansion-filing-gets-priority-review"}, {"symbol": "PFE", "publishedDate": "2019-08-22 07:30:00", "title": "3 Dividend Stocks That Pay Better Than Coca-Cola.", "image": "https://cdn.snapi.dev/images/v1/n/4/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5373342f18-08-21-a-jar-of-coins-with-the-word-dividends-on-it-gettyimages-545379302jpgw700opresize.jpg", "site": "The Motley Fool", "text": "Coke's yield is a juicy 3% or so. But you can do better!", "url": "https://www.fool.com/investing/2019/08/22/3-dividend-stocks-that-pay-better-than-coca-cola.aspx"}, {"symbol": "PFE", "publishedDate": "2019-08-22 13:39:31", "title": "Pfizer Digs Deeper Into Gene Therapy, Rivaling These Biotech Stocks", "image": "https://cdn.snapi.dev/images/v1/f/w/drugs18.jpg", "site": "Investors Business Daily", "text": "Pfizer stock jumped Wednesday after the Dow Jones giant announced a big push into gene therapy manufacturing as it tackles Duchenne muscular dystrophy and hemophilia B.", "url": "https://www.investors.com/news/technology/pfizer-stock-rises-investment-gene-therapy-manufacturing/"}, {"symbol": "PFE", "publishedDate": "2019-08-22 09:20:24", "title": "Trade of the Day: Pfizer Stock Is Flashing Attractive Buy Signals", "image": "https://cdn.snapi.dev/images/v1/r/v/pf9-3.jpg", "site": "InvestorPlace", "text": "PFE stock recently dropped 20% following the company's latest earnings report. As a result, Pfizer has reached extreme oversold readings that could lead to a pop in the stock.", "url": "https://investorplace.com/2019/08/trade-of-the-day-pfizer-stock-is-flashing-attractive-buy-signals/"}, {"symbol": "PFE", "publishedDate": "2019-08-20 15:11:01", "title": "3 Healthcare Stocks to Trade: UNH, JNJ and PFE", "image": "https://cdn.snapi.dev/images/v1/a/l/etf24-51.jpg", "site": "InvestorPlace", "text": "Even though they are prone to headlines during elections, here are 3 healthcare stocks to buy: PFE, UNH and JNJ.\r\nThe post 3 Healthcare Stocks to Trade: UNH, JNJ and PFE appeared first on InvestorPlace.", "url": "https://investorplace.com/2019/08/3-healthcare-stocks-to-trade-unh-jnj-and-pfe/"}, {"symbol": "PFE", "publishedDate": "2019-08-15 13:26:42", "title": "Pfizer recalls two lots of migraine drug due to potential bacterial contamination", "image": "https://cdn.snapi.dev/images/v1/f/z/drugs9.jpg", "site": "Market Watch", "text": "Pfizer Inc. PFE, +0.23% is recalling two lots of its migraine medication Relpax, the U.S. Food and Drug Administration said Thursday.", "url": "https://www.marketwatch.com/story/pfizer-recalls-two-lots-of-migraine-drug-due-to-potential-bacterial-contamination-2019-08-15"}, {"symbol": "PFE", "publishedDate": "2019-08-13 09:30:33", "title": "Tuesday\u2019s Vital Data: Uber, Pfizer and Roku", "image": "https://cdn.snapi.dev/images/v1/5/c/stocks1600-768x432.jpg", "site": "InvestorPlace", "text": "Options trading was buzzing in Uber, Pfizer and Roku on Monday. Here are the metrics that matter moving forward.", "url": "https://investorplace.com/2019/08/tuesdays-vital-data-uber-pfizer-and-roku/"}, {"symbol": "PFE", "publishedDate": "2019-08-13 06:00:00", "title": "5 Biggest New Drugs Approved in 2019 So Far", "image": "https://cdn.snapi.dev/images/v1/c/8/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5366262fwhite-pill-with-dollar-symboljpgw700opresize.jpg", "site": "The Motley Fool", "text": "And the one big pharma most likely to benefit the most.", "url": "https://www.fool.com/investing/2019/08/13/5-biggest-new-drugs-approved-in-2019-so-far.aspx"}, {"symbol": "PFE", "publishedDate": "2019-08-12 13:57:31", "title": "Pfizer's stock sinks again, toward 14-month low to pace 'Dow's' losers", "image": "https://cdn.snapi.dev/images/v1/p/v/drugs14.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. PFE, -3.52% dropped 3.6% in afternoon grading Monday, putting them on track to close at a 14-month low, as the drugmaker extends the rough patch in the wake of its second-quarter earnings report and announcement to merge its Upjohn business with Mylan Inc.", "url": "https://www.marketwatch.com/story/pfizers-stock-sinks-again-toward-14-month-low-to-pace-dows-losers-2019-08-12"}, {"symbol": "PFE", "publishedDate": "2019-08-12 06:35:20", "title": "Pfizer Once Again the Most Shorted Dow Stock", "image": "https://cdn.snapi.dev/images/v1/5/g/chemicals15.jpg", "site": "24/7 Wall Street", "text": "It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components.", "url": "https://247wallst.com/investing/2019/08/12/pfizer-once-again-the-most-shorted-dow-stock/"}, {"symbol": "PFE", "publishedDate": "2019-08-06 09:30:13", "title": "SNY vs. PFE: Which Stock Is the Better Value Option?", "image": "https://cdn.snapi.dev/images/v1/z/u/drugs10.jpg", "site": "Zacks Investment Research", "text": "SNY vs. PFE: Which Stock Is the Better Value Option?", "url": "https://www.zacks.com/stock/news/459725/sny-vs-pfe-which-stock-is-the-better-value-option"}, {"symbol": "PFE", "publishedDate": "2019-08-06 08:19:40", "title": "3 Big Stock Charts for Tuesday: Pfizer, AES and Centurylink", "image": "https://cdn.snapi.dev/images/v1/i/o/etf13-35.jpg", "site": "InvestorPlace", "text": "The stock charts of Pfizer, AES and Centurylink have emerged as enticing prospects within a sea of volatility.\r\nThe post 3 Big Stock Charts for Tuesday: Pfizer, AES and Centurylink appeared first on InvestorPlace.", "url": "https://investorplace.com/2019/08/3-big-stock-charts-for-tuesday-pfizer-aes-and-centurylink/"}, {"symbol": "PFE", "publishedDate": "2019-08-04 09:00:00", "title": "These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024", "image": "https://cdn.snapi.dev/images/v1/s/9/385.jpg", "site": "The Motley Fool", "text": "These five-star medicines should continue to push the industry higher in the next decade, despite the political blowback surrounding U.S. prescription drug prices.", "url": "https://www.fool.com/investing/2019/08/04/the-top-5-best-selling-prescription-drugs.aspx"}, {"symbol": "PFE", "publishedDate": "2019-08-02 09:32:53", "title": "Fitch Ratings downgrades Pfizer to A vs. A-plus with negative outlook", "image": "https://cdn.snapi.dev/images/v1/n/7/drugs40.jpg", "site": "Market Watch", "text": "Fitch Ratings downgraded Pfizer Inc.'s long-term issuer default rating by one notch to A from A-plus on Friday, after the closing of the acquisition of Array BioPharma earlier this week.", "url": "https://www.marketwatch.com/story/fitch-ratings-downgrades-pfizer-to-a-vs-a-plus-with-negative-outlook-2019-08-02-9913253"}, {"symbol": "PFE", "publishedDate": "2019-08-02 09:06:00", "title": "The 'Dogs Of The Dow' For 2019 Stalled In July", "image": "https://cdn.snapi.dev/images/v1/e/t/etf48-33.jpg", "site": "Forbes", "text": "The eight \u201cDogs of the Dow\u201d have an aggregate year-to-date gain of 12.2%, lagging the Dow Jones Industrial Average, which is up 15.2%.", "url": "https://www.forbes.com/sites/investor/2019/08/02/the-dogs-of-the-dow-for-2019-stalled-in-july/"}, {"symbol": "PFE", "publishedDate": "2019-07-31 14:00:08", "title": "5 Stocks to Buy and Keep an Eye on Come Fall", "image": "https://cdn.snapi.dev/images/v1/e/t/etf13-59.jpg", "site": "InvestorPlace", "text": "Q2 earnings season rolls on and Wall Street tries to not act disappointed by the early end to the latest round of U.S.-China trade talks.", "url": "https://investorplace.com/2019/07/5-stocks-to-buy-and-keep-an-eye-on-come-fall/"}, {"symbol": "PFE", "publishedDate": "2019-07-31 13:50:20", "title": "Square ahead of earnings, plus the Boeing trade in #AskHalftime", "image": "https://cdn.snapi.dev/images/v1/y/w/square-ahead-of-earnings-plus-the-boeing-trade-in-askhalftime.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions on Square, Boeing, Pfizer, & Nokia.", "url": "https://www.youtube.com/watch?v=dGUpSqSmCD4"}, {"symbol": "PFE", "publishedDate": "2019-07-31 10:01:27", "title": "Wednesday\u2019s Vital Data: Pfizer, Advanced Micro Devices and Apple", "image": "https://cdn.snapi.dev/images/v1/r/q/4srj-7.jpg", "site": "InvestorPlace", "text": "Options trading was buzzing in Pfizer, Advanced Micro Devices and Apple on Tuesday. Here are the metrics that matter moving forward.", "url": "https://investorplace.com/2019/07/wednesdays-vital-data-pfizer-advanced-micro-devices-and-apple/"}, {"symbol": "PFE", "publishedDate": "2019-07-31 05:01:52", "title": "Here\u2019s How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal", "image": "https://cdn.snapi.dev/images/v1/k/p/drugs2.jpg", "site": "InvestorPlace", "text": "The new company emerging from the Pfizer-Mylan deal gets former blockbusters like Lipitor and Celebrex, now generics, and the EpiPen business, which has been an object of scandal.\r\nThe post Here\u2019s How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal appeared first on InvestorPlace.", "url": "https://investorplace.com/2019/07/heres-how-pfizer-stock-and-pharma-stand-to-benefit-from-mylan-deal/"}, {"symbol": "PFE", "publishedDate": "2019-07-30 16:32:00", "title": "Why Beyond Meat, McDermott International, and Pfizer Slumped Today", "image": "https://cdn.snapi.dev/images/v1/e/l/sto2934.jpg", "site": "The Motley Fool", "text": "Sometimes even solid growth isn't enough to lift a stock's price.", "url": "https://www.fool.com/investing/2019/07/30/why-beyond-meat-mcdermott-international-and-pfizer.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-30 15:51:17", "title": "5 Top Stock Trades for Wednesday (July 31)", "image": "https://cdn.snapi.dev/images/v1/8/b/8b-10.jpg", "site": "InvestorPlace", "text": "Under Armour, PepsiCo, Invitae, Capital One and Pfizer are our top stock trades for Wednesday. Here's how to trade them.", "url": "https://investorplace.com/2019/07/5-top-stock-trades-for-wednesday-uaa-pep-nvta/"}, {"symbol": "PFE", "publishedDate": "2019-07-30 13:41:23", "title": "Pfizer Becomes a Falling Knife After Monday's Earnings", "image": "https://cdn.snapi.dev/images/v1/d/n/pfizer5.jpg", "site": "Investopedia", "text": "The pharma giant beat EPS estimates but missed on revenue, with sales suffering from major drugs that are now offered as generics.", "url": "https://www.investopedia.com/pfizer-became-a-falling-knife-after-mondays-earnings-4707595"}, {"symbol": "PFE", "publishedDate": "2019-07-30 12:14:41", "title": "Morgan Stanley Downgrades Pfizer In Wake Of Upjohn-Mylan Merger", "image": "https://cdn.snapi.dev/images/v1/w/3/pfi88.jpg", "site": "Benzinga", "text": "Morgan Stanley downgraded Pfizer Inc (NYSE: PFE)\u00a0Tuesday after the drug company announced the\u00a0spinoff of its Upjohn division\u00a0on Monday, sending its stock downward.", "url": "https://www.benzinga.com/analyst-ratings/analyst-color/19/07/14160768/morgan-stanley-downgrades-pfizer-in-wake-of-upjohn-mylan-merger"}, {"symbol": "PFE", "publishedDate": "2019-07-30 10:15:56", "title": "Pfizer's stock tumbles toward worst 2-day stretch in 10 1/2-years", "image": "https://cdn.snapi.dev/images/v1/l/w/pfi9.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. PFE, -5.30% tumbled 5.2% to pace the Dow Jones Industrial Average's DJIA, -0.18% decliners in morning trading Tuesday, after Bank of America Merrill Lynch analyst Jason Gerberry downgraded the drug maker in the wake of the deal in which the company's Upjohn business will merge with generic drugmaker Mylan N.V.", "url": "https://www.marketwatch.com/story/pfizers-stock-tumbles-toward-worst-2-day-stretch-in-10-12-years-2019-07-30"}, {"symbol": "PFE", "publishedDate": "2019-07-30 07:58:00", "title": "Morgan Stanley downgrades Pfizer, says Mylan sale this week revealed some bad news", "image": "https://cdn.snapi.dev/images/v1/n/c/103890274-gettyimages-537929536.jpg", "site": "CNBC", "text": "Morgan Stanley downgraded Pfizer to equal-weight from overweight and slashed it price target to $40 per share from $48 per share.", "url": "https://www.cnbc.com/2019/07/30/morgan-stanley-downgrades-pfizer-says-mylan-sale-this-week-revealed-some-bad-news.html"}, {"symbol": "PFE", "publishedDate": "2019-07-30 06:00:00", "title": "3 Key Things to Know About How the Mylan-Upjohn Merger Affects Pfizer Shareholders", "image": "https://cdn.snapi.dev/images/v1/h/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5241922fpills-with-some-in-shape-of-dollar-dignjpgampw700ampopresize.jpg", "site": "The Motley Fool", "text": "Pfizer's proposed deal with Mylan is complicated. But if you're a Pfizer shareholder, here's what you need to know.", "url": "https://www.fool.com/investing/2019/07/30/3-key-things-to-know-about-how-the-mylan-upjohn-me.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-29 18:23:47", "title": "Jefferies' Holz: Pfizer, Mylan deal not seen as defensive, both business in 'tight spaces'", "image": "https://cdn.snapi.dev/images/v1/s/x/jefferies-holz-pfizer-mylan-deal-not-seen-as-defensive-both-business-in-tight-spaces.jpg", "site": "CNBC Television", "text": "Jared Holz, health care sector strategist at Jefferies, and Chris Meekins, research analyst at Raymond James, join CNBC's \"Closing Bell\" to discuss the new deal between Pfizer and Mylan, as well as presidential hopeful Sen.", "url": "https://www.youtube.com/watch?v=h-jMerEtae8"}, {"symbol": "PFE", "publishedDate": "2019-07-29 16:58:58", "title": "Health-Care M&A Takes Center Stage With Mylan-Pfizer, Exact-Genomic Deals", "image": "https://cdn.snapi.dev/images/v1/t/4/health-care-ma-takes-center-stage-with-mylan-pfizer-exact-genomic-deals.jpg", "site": "Bloomberg Markets and Finance", "text": "Bloomberg's Nabila Ahmed takes a look at the latest M&A activity in the health-care industry. She speaks on \"Bloomberg Markets: The Close.\"", "url": "https://www.youtube.com/watch?v=IIJWnr20HFc"}, {"symbol": "PFE", "publishedDate": "2019-07-29 16:35:06", "title": "Pfizer Inc. (PFE) CEO Albert Bourla on Q2 2019 Results - Earnings Call Transcript", "image": "https://cdn.snapi.dev/images/v1/m/n/transcript40.jpg", "site": "Seeking Alpha", "text": "Pfizer Inc. (PFE) CEO Albert Bourla on Q2 2019 Results - Earnings Call Transcript", "url": "https://seekingalpha.com/article/4278771-pfizer-inc-pfe-ceo-albert-bourla-q2-2019-results-earnings-call-transcript?source=feed_sector_transcripts"}, {"symbol": "PFE", "publishedDate": "2019-07-29 16:24:00", "title": "How Big Is Pfizer's Generic Drugs Business That It Plans To Merge With Mylan?", "image": "https://cdn.snapi.dev/images/v1/1/g/drugs20.jpg", "site": "Forbes", "text": "Pfizer (NYSE:PFE) today announced its plan to combine its generic drugs business with Mylan in a Reverse Morris Trust transaction. The combined entity could generate sales of over $20 billion by 2020, and Pfizer will hold a 57% stake in the new company, with Mylan holding the rest.", "url": "https://www.forbes.com/sites/greatspeculations/2019/07/29/how-big-is-pfizers-generic-drugs-business-that-it-plans-to-merge-with-mylan/"}, {"symbol": "PFE", "publishedDate": "2019-07-29 15:31:56", "title": "Mylan, Pfizer combined could generate more than $19 billion in annual sales: Analyst", "image": "https://cdn.snapi.dev/images/v1/m/b/mylan-pfizer-combined-could-generate-more-than-19-billion-in-annual-sales-analyst.jpg", "site": "CNBC Television", "text": "CNBC's \"Power Lunch\" team and Meg Tirrell discuss generic drug makers with Irina Koffler of Mizuho Securities.", "url": "https://www.youtube.com/watch?v=zZ_XFHmbFvc"}, {"symbol": "PFE", "publishedDate": "2019-07-29 14:00:00", "title": "What You'll Want to Know About Pfizer's Q2 Earnings Results", "image": "https://cdn.snapi.dev/images/v1/0/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5331082fpills-with-some-in-shape-of-dollar-dignjpgw700opresize.jpg", "site": "The Motley Fool", "text": "No big surprises with Pfizer's Q2 earnings results. The big surprise was a major deal with Mylan that caused the results to be announced earlier than expected.", "url": "https://www.fool.com/investing/2019/07/29/what-youll-want-to-know-about-pfizers-q2-earnings.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-29 13:05:00", "title": "Pfizer Inc to Combine Off-Patent Drug Business With Mylan NV", "image": "https://cdn.snapi.dev/images/v1/x/h/drugs15.jpg", "site": "GuruFocus", "text": "Drugmaker Pfizer Inc. (NYSE:PFE) announced on Monday it is combining its off-patent drug business, which is called Upjohn, with Pittsburgh-based generic pharmaceutical giant Mylan NV (NASDAQ:MYL) in an all-stock deal, creating a new company.", "url": "https://www.gurufocus.com/news/917420/pfizer-to-combine-offpatent-drug-business-with-mylan"}, {"symbol": "PFE", "publishedDate": "2019-07-29 13:03:28", "title": "Mylan-Pfizer Deal: MYL Stock Soars on Off-Patent Drug Merger", "image": "https://cdn.snapi.dev/images/v1/t/v/drugs13.jpg", "site": "InvestorPlace", "text": "A new Mylan-Pfizer deal that will have the companies taking part in a merger agreement has MYL stock heading higher on Monday.\nThe post Mylan-Pfizer Deal: MYL Stock Soars on Off-Patent Drug Merger appeared first on InvestorPlace.", "url": "https://investorplace.com/2019/07/mylan-pfizer-deal-has-myl-stock-up/"}, {"symbol": "PFE", "publishedDate": "2019-07-29 12:38:56", "title": "Pfizer to merge off-patent drug business with Mylan", "image": "https://cdn.snapi.dev/images/v1/e/n/pfizer-to-merge-off-patent-drug-business-with-mylan.jpg", "site": "Yahoo Finance", "text": "Yahoo Finance's Anjalee Khemlani reports on the Pharmaceutical Giants Pfizer and Mylan have reached.", "url": "https://www.youtube.com/watch?v=86KbecWWBAg"}, {"symbol": "PFE", "publishedDate": "2019-07-29 12:31:18", "title": "Pfizer to spinoff, merge off-patent drugs unit with Mylan", "image": "https://cdn.snapi.dev/images/v1/f/f/drugs16jpg.jpg", "site": "Reuters", "text": "Pfizer Inc  has agreed to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV , a move that leaves Pfizer with its more profitable innovative drugs, including cancer treatment Ibrance and pneumonia vaccine Prevnar.", "url": "https://www.reuters.com/article/us-mylan-pfizer/pfizer-to-spinoff-merge-off-patent-drugs-unit-with-mylan-idUSKCN1UO185"}, {"symbol": "PFE", "publishedDate": "2019-07-29 12:05:22", "title": "What to Watch When Merck and Pfizer Report Early on Tuesday", "image": "https://cdn.snapi.dev/images/v1/f/j/drugs11.jpg", "site": "24/7 Wall Street", "text": "Pfizer Inc. (NYSE: PFE) and Merck & Co. Inc. (NYSE: MRK) are each scheduled to release their second-quarter financial results before the markets open on Tuesday.", "url": "https://247wallst.com/healthcare-business/2019/07/29/what-to-watch-when-merck-and-pfizer-report-early-on-tuesday/"}, {"symbol": "PFE", "publishedDate": "2019-07-29 11:44:26", "title": "Pfizer in talks to transition EpiPen maker into generics spinoff: spokeswoman", "image": "https://cdn.snapi.dev/images/v1/p/f/pf9-5.jpg", "site": "Reuters", "text": "Pfizer Inc. is in talks to merge its contract manufacturer that produces Mylan\u2019s EpiPen emergency allergy treatment into the new generics business it is creating by combining its older off-patent medicines unit with Mylan NV (MYL.O), a Pfizer spokeswoman said.", "url": "https://www.reuters.com/article/us-mylan-pfizer-epipen/pfizer-in-talks-to-transition-epipen-maker-into-generics-spinoff-spokeswoman-idUSKCN1UO1SG"}, {"symbol": "PFE", "publishedDate": "2019-07-29 11:40:53", "title": "Stock Market News: Pfizer and Mylan Make a Deal; Chipotle Looks Tasty", "image": "https://cdn.snapi.dev/images/v1/a/2/stocks1600-768x432.jpg", "site": "The Motley Fool", "text": "Stocks were mixed on Wall Street Monday morning.", "url": "https://www.fool.com/investing/2019/07/29/stock-market-news-pfizer-mylan-make-a-deal-chipotl.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-29 11:16:29", "title": "Mylan CEO to depart as part of deal with Pfizer's off-patent drug business", "image": "https://cdn.snapi.dev/images/v1/o/o/ook92-1.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports on Pfizer's move to combine its off-patent drug business with Mylan, whose CEO Heather Bresch will depart as part of the deal.", "url": "https://www.youtube.com/watch?v=Kp8vDagElNQ"}, {"symbol": "PFE", "publishedDate": "2019-07-29 11:04:00", "title": "Pfizer (PFE) Beats on Q2 Earnings, to Merge Upjohn With Mylan", "image": "https://cdn.snapi.dev/images/v1/k/s/drugs10.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) beats estimates for second-quarter earnings but misses on sales. The company also lowers 2019 earnings and sales guidance.", "url": "https://www.zacks.com/stock/news/452910/pfizer-pfe-beats-on-q2-earnings-to-merge-upjohn-with-mylan"}, {"symbol": "PFE", "publishedDate": "2019-07-29 10:59:49", "title": "It's Market Madness: Jim Cramer on Earnings Season, Pfizer and Mylan, Starbucks", "image": "https://cdn.snapi.dev/images/v1/r/z/its-market-madness-jim-cramer-on-earnings-season-pfizer-and-mylan-starbucks.jpg", "site": "The Street", "text": "Jim weighs in on Pfizer and Mylan, Starbucks and, of course, the causes for a week of market madness.", "url": "https://www.youtube.com/watch?v=huoAr0MFBeE"}, {"symbol": "PFE", "publishedDate": "2019-07-29 10:52:59", "title": "Merger Fever Runs Hot In Pharma As Pfizer, Mylan Announce Matchup", "image": "https://cdn.snapi.dev/images/v1/m/y/mypf92-1.jpg", "site": "Investors Business Daily", "text": "Pfizer announced an all-stock plan Monday to combine its off-patent and generic drugs unit, Upjohn, with pharmaceutical company Mylan\u00a0\u2014 sending Mylan stock flying as Pfizer stock stumbled.\r\nThe post Merger Fever Runs Hot In Pharma As Pfizer, Mylan Announce Matchup appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/pharmaceutical-companies-pfizer-upjohn-combine-mylan-generic-drugs/"}, {"symbol": "PFE", "publishedDate": "2019-07-29 10:19:54", "title": "S&P downgrades Pfizer by one notch to AA-minus after Upjohn/Mylan deal", "image": "https://cdn.snapi.dev/images/v1/p/f/pfz-2.jpg", "site": "Market Watch", "text": "S&P Global Ratings downgraded Pfizer Inc.'s ratings by one notch to AA-minus Monday, after the company said it is divesting its Upjohn generics business and merging it with Mylan Plc.", "url": "https://www.marketwatch.com/story/sp-downgrades-pfizer-by-one-notch-to-aa-minus-after-upjohnmylan-deal-2019-07-29"}, {"symbol": "PFE", "publishedDate": "2019-07-29 10:12:00", "title": "What's in Store for Array BioPharma (ARRY) in Q4 Earnings?", "image": "https://cdn.snapi.dev/images/v1/e/8/biotech3.jpg", "site": "Zacks Investment Research", "text": "Array BioPharma's (ARRY) Braftovi-Mektovi combination therapy is likely to drive fourth-quarter sales.", "url": "https://www.zacks.com/stock/news/452742/whats-in-store-for-array-biopharma-arry-in-q4-earnings"}, {"symbol": "PFE", "publishedDate": "2019-07-29 09:41:54", "title": "Pfizer to merge generics unit with Mylan; seeks to sharpen cancer focus", "image": "https://cdn.snapi.dev/images/v1/v/o/drugs29.jpg", "site": "Reuters", "text": "Drugmaker Pfizer Inc  has agreed to spin off its generic drugs business and combine it with Mylan , a move that leaves Pfizer with more profitable innovative drugs, including cancer drug Ibrance and pneumonia vaccine Prevnar.", "url": "https://www.reuters.com/article/us-mylan-pfizer/pfizer-to-merge-generics-unit-with-mylan-seeks-to-sharpen-cancer-focus-idUSKCN1UO185"}, {"symbol": "PFE", "publishedDate": "2019-07-29 09:25:24", "title": "What This Mylan-Pfizer Pharma Juggernaut Will Look Like", "image": "https://cdn.snapi.dev/images/v1/l/n/drugs50.jpg", "site": "24/7 Wall Street", "text": "Mylan N.V. (NASDAQ: MYL) released its second-quarter financial results before the markets opened on Monday.", "url": "https://247wallst.com/healthcare-business/2019/07/29/what-this-mylan-pfizer-pharma-juggernaut-will-look-like/"}, {"symbol": "PFE", "publishedDate": "2019-07-29 09:07:00", "title": "Pfizer Closes in on a Major Spinoff", "image": "https://cdn.snapi.dev/images/v1/m/x/pfi88.jpg", "site": "The Motley Fool", "text": "The pharmaceutical giant will reportedly combine its legacy products business with generic drug major Mylan.", "url": "https://www.fool.com/investing/2019/07/29/pfizer-closes-in-on-a-major-spinoff.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-29 08:56:18", "title": "Pfizer stock down after revenue miss, merger announcement", "image": "https://cdn.snapi.dev/images/v1/4/o/pfi9.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. PFE, +0.98% fell 3% in premarket trade Monday after the company announced a deal to merge its Upjohn business with Mylan and reported second-quarter earnings that topped profit expectations, though the drugmaker fell short of revenue estimates.", "url": "https://www.marketwatch.com/story/pfizer-stock-down-after-revenue-miss-merger-announcement-2019-07-29"}, {"symbol": "PFE", "publishedDate": "2019-07-29 08:23:15", "title": "Pfizer to Merge Off-Patent Unit With Mylan in All-Stock Deal", "image": "https://cdn.snapi.dev/images/v1/x/z/pfizer-to-merge-off-patent-unit-with-mylan-in-all-stock-deal.jpg", "site": "Bloomberg Markets and Finance", "text": "Pfizer Inc. will combine its business line of older blockbuster medicines in an all-stock deal with generic drugmaker Mylan NV. Bloomberg Intelligence's Sam Fazeli has the details on \"Bloomberg Daybreak: Americas.\"", "url": "https://www.youtube.com/watch?v=OsfX0od-x4I"}, {"symbol": "PFE", "publishedDate": "2019-07-29 08:05:04", "title": "Pfizer (PFE) Q2 Earnings Top Estimates", "image": "https://cdn.snapi.dev/images/v1/e/q/drugs47.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) delivered earnings and revenue surprises of 3.90% and -0.44%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?", "url": "https://www.zacks.com/stock/news/452520/pfizer-pfe-q2-earnings-top-estimates"}, {"symbol": "PFE", "publishedDate": "2019-07-29 08:01:01", "title": "Mylan, Pfizer's Upjohn To Merge And Create New Company", "image": "https://cdn.snapi.dev/images/v1/c/p/medications-257336-1920-50.jpg", "site": "Benzinga", "text": "Mylan (NASDAQ: MYL) shares are trading higher after it announced the launch of a new company with Pfizer's (NYSE: PFE) Upjohn division.", "url": "https://www.benzinga.com/m-a/19/07/14149338/mylan-pfizers-upjohn-to-merge-and-create-new-company"}, {"symbol": "PFE", "publishedDate": "2019-07-29 07:56:40", "title": "Pfizer Reports Mixed Q2 Earnings, Lowers Guidance", "image": "https://cdn.snapi.dev/images/v1/b/i/biotech23-10.jpg", "site": "Benzinga", "text": "Pfizer (NYSE: PFE) reported quarterly earnings of 80 cents per share, which beat the analyst consensus estimate of 75 cents by 6.67%.", "url": "https://www.benzinga.com/news/earnings/19/07/14149282/pfizer-reports-mixed-q2-earnings-lowers-guidance"}, {"symbol": "PFE", "publishedDate": "2019-07-29 07:40:25", "title": "Buy Pfizer Stock Before this Week\u2019s Earnings Report Gives It a Bump Up", "image": "https://cdn.snapi.dev/images/v1/s/7/drugs41.jpg", "site": "InvestorPlace", "text": "As it prepares to report its second-quarter earnings, Pfizer Stock is set to make some big moves. Now is the time to get in.", "url": "https://investorplace.com/2019/07/buy-pfizer-stock-before-this-weeks-earnings-report-gives-it-a-bump-up/"}, {"symbol": "PFE", "publishedDate": "2019-07-29 07:35:12", "title": "Mylan CEO Heather Bresch to retire after deal to merge with Pfizer's Upjohn closes", "image": "https://cdn.snapi.dev/images/v1/r/y/drugs40.jpg", "site": "Market Watch", "text": "Mylan N.V. MYL, +0.11% said that in connection with the deal to merge with Pfizer Inc.", "url": "https://www.marketwatch.com/story/mylan-ceo-heather-bresch-to-retire-after-deal-to-merge-with-pfizers-upjohn-closes-2019-07-29"}, {"symbol": "PFE", "publishedDate": "2019-07-29 07:08:27", "title": "Pfizer to combine off-patent drug business with Mylan", "image": "https://cdn.snapi.dev/images/v1/i/i/ii292-1.jpg", "site": "CNBC Television", "text": "CNBC's Meg Tirrell reports on a new Pharma deal between Pfizer and Mylan.", "url": "https://www.youtube.com/watch?v=BqzZYdPOI7g"}, {"symbol": "PFE", "publishedDate": "2019-07-29 07:06:05", "title": "Pfizer posts 30% rise in quarterly profit", "image": "https://cdn.snapi.dev/images/v1/l/m/m02d20190729t2i1413211723rlynxnpef6s0ucw640.jpg", "site": "Reuters", "text": "Pfizer Inc  on Monday reported a 30% rise in quarterly profit, helped by demand for its branded treatments such as Ibrance, Eliquis and Xeljanz.", "url": "https://www.reuters.com/article/us-pfizer-results/pfizer-posts-30-rise-in-quarterly-profit-idUSKCN1UO18S"}, {"symbol": "PFE", "publishedDate": "2019-07-29 07:03:56", "title": "Mylan to combine with Pfizer's off-patent medicines unit", "image": "https://cdn.snapi.dev/images/v1/l/y/my723-2.jpg", "site": "Reuters", "text": "Mylan NV  said on Monday it would combine with Pfizer Inc's  off-patent branded and generic established medicines business to form a global generic drugmaker.", "url": "https://www.reuters.com/article/us-mylan-pfizer/mylan-to-combine-with-pfizers-off-patent-medicines-unit-idUSKCN1UO185"}, {"symbol": "PFE", "publishedDate": "2019-07-29 06:59:17", "title": "Mylan's stock soars after deal to merger with Pfizer's Upjohn", "image": "https://cdn.snapi.dev/images/v1/6/9/drugs38.jpg", "site": "Market Watch", "text": "Shares of Mylan N.V. MYL, +0.11% soared 24% in premarket trading Monday, after the generic drug maker confirmed it was merging with Pfizer Inc.", "url": "https://www.marketwatch.com/story/mylans-stock-soars-after-deal-to-merger-with-pfizers-upjohn-2019-07-29"}, {"symbol": "PFE", "publishedDate": "2019-07-29 06:30:00", "title": "3 Things to Look For in Pfizer's Q2 Earnings Update", "image": "https://cdn.snapi.dev/images/v1/8/k/pfizer5.jpg", "site": "The Motley Fool", "text": "The big drugmaker announces its Q2 results on July 30. Here's what you can expect.", "url": "https://www.fool.com/investing/2019/07/29/3-things-to-look-for-in-pfizers-q2-earnings-update.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-28 17:33:00", "title": "Pfizer plans combination of off-patent drug business with Mylan", "image": "https://cdn.snapi.dev/images/v1/0/a/103606723-rtx2cq0n.jpg", "site": "CNBC", "text": "The deal, expected to be announced Monday, will result in Pfizer shareholders owning most of the new company with Mylan's shareholders owning slightly more than 40%.", "url": "https://www.cnbc.com/2019/07/28/pfizer-plans-combination-of-off-patent-drug-business-with-mylan.html"}, {"symbol": "PFE", "publishedDate": "2019-07-27 12:20:00", "title": "10 Biggest Cancer-Fighting Stocks", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5193592fabt-earnings-41719.jpg", "site": "The Motley Fool", "text": "The fight against cancer is a big battle. And these 10 companies are among the biggest combatants you can invest in.", "url": "https://www.fool.com/investing/2019/07/27/10-biggest-cancer-fighting-stocks.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-27 09:04:02", "title": "Pfizer in talks to merge off-patent drugs business with Mylan", "image": "https://cdn.snapi.dev/images/v1/j/z/m02d20190727t2i1412584697rlynxnpef6q0b3w640.jpg", "site": "Reuters", "text": "Pfizer Inc  is in talks to merge its off-patent drugs business with Mylan NV  in a stock deal, the Wall Street Journal reported on Saturday, citing people familiar with the matter.", "url": "https://www.reuters.com/article/us-mylan-nl-m-a-pfizer/pfizer-in-talks-to-merge-off-patent-drugs-business-with-mylan-idUSKCN1UM0DP"}, {"symbol": "PFE", "publishedDate": "2019-07-25 09:00:08", "title": "Array BioPharma (ARRY) Moves to Buy: Rationale Behind the Upgrade", "image": "https://cdn.snapi.dev/images/v1/w/e/biotech5.jpg", "site": "Zacks Investment Research", "text": "Array BioPharma (ARRY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.", "url": "https://www.zacks.com/stock/news/449331/array-biopharma-arry-moves-to-buy-rationale-behind-the-upgrade"}, {"symbol": "PFE", "publishedDate": "2019-07-25 06:40:09", "title": "Intel Overtakes Pfizer as Most Shorted Dow Stock", "image": "https://cdn.snapi.dev/images/v1/e/t/etf30-54.jpg", "site": "24/7 Wall Street", "text": "It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components.", "url": "https://247wallst.com/investing/2019/07/25/intel-overtakes-pfizer-as-most-shorted-dow-stock/"}, {"symbol": "PFE", "publishedDate": "2019-07-24 18:41:00", "title": "Can Pfizer's Q2 Earnings Help Boost PFE Stock in a Struggling Pharma Market?", "image": "https://cdn.snapi.dev/images/v1/t/c/drugs39.jpg", "site": "Zacks Investment Research", "text": "Pfizer Inc. (PFE) is set to report its Q2 earnings results on Tuesday, July 30.", "url": "https://www.zacks.com/stock/news/448975/can-pfizers-q2-earnings-help-boost-pfe-stock-in-a-struggling-pharma-market"}, {"symbol": "PFE", "publishedDate": "2019-07-23 10:32:19", "title": "Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for", "image": "https://cdn.snapi.dev/images/v1/j/f/drugs3.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.", "url": "https://www.zacks.com/stock/news/447566/analysts-estimate-pfizer-pfe-to-report-a-decline-in-earnings-what-to-look-out-for"}, {"symbol": "PFE", "publishedDate": "2019-07-21 09:00:00", "title": "Better Buy:  Pfizer vs.  AbbVie", "image": "https://cdn.snapi.dev/images/v1/x/a/top23.jpg", "site": "The Motley Fool", "text": "Which stock wins in a head-to-head matchup between these two big drugmakers?", "url": "https://www.fool.com/investing/2019/07/21/better-buy-pfizer-vs-abbvie.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-20 09:00:00", "title": "3 Stocks to Build Your Portfolio Around: Google, Pfizer & W.P. Carey", "image": "https://cdn.snapi.dev/images/v1/l/w/sto23-3.jpg", "site": "The Motley Fool", "text": "It needs a solid foundation, and Alphabet, Pfizer, and W.P. Carey have proven their worth over time.", "url": "https://www.fool.com/investing/2019/07/20/3-stocks-to-build-your-portfolio-around.aspx"}, {"symbol": "PFE", "publishedDate": "2019-07-16 21:00:12", "title": "Sangamo's Hemophilia A Results Light A Spark And Push Program Into Pfizer's Hands", "image": "https://cdn.snapi.dev/images/v1/b/l/drugs3.jpg", "site": "Seeking Alpha", "text": "Sangamo Therapeutics reports positive results from its phase 1/2 open-label study using SB-525 to treat patients with Hemophilia A.", "url": "https://seekingalpha.com/article/4275320-sangamos-hemophilia-results-light-spark-push-program-pfizers-hands?source=feed_tag_long_ideas"}, {"symbol": "PFE", "publishedDate": "2019-07-12 11:35:00", "title": "Drug Pricing Woes Linger on Repealing Drug Rebate Proposal", "image": "https://cdn.snapi.dev/images/v1/u/n/drugs41.jpg", "site": "Zacks Investment Research", "text": "Investors' skepticism runs rife as Trump drops the drug rebate proposal, pushing drugmakers to take center stage with regard to the controversial drug pricing issue.", "url": "https://www.zacks.com/stock/news/441711/drug-pricing-woes-linger-on-repealing-drug-rebate-proposal"}, {"symbol": "PFE", "publishedDate": "2019-07-12 09:30:17", "title": "SNY or PFE: Which Is the Better Value Stock Right Now?", "image": "https://cdn.snapi.dev/images/v1/r/a/drugs34.jpg", "site": "Zacks Investment Research", "text": "SNY vs. PFE: Which Stock Is the Better Value Option?", "url": "https://www.zacks.com/stock/news/441539/sny-or-pfe-which-is-the-better-value-stock-right-now"}, {"symbol": "PFE", "publishedDate": "2019-07-11 15:19:00", "title": "These are the stocks that have powered the Dow's rally to 27,000", "image": "https://cdn.snapi.dev/images/v1/1/0-3/105981729-15611309300202019-06-05t145625z-1590043122-rc11ed42bf00-rtrmadp-3-usa-stocks.jpg", "site": "CNBC", "text": "The Dow Jones Industrial Average surged above 27,000 for the first time ever on Thursday, just a day after the S&P 500 topped 3,000. Here's a look at the stocks that drove the rally.", "url": "https://www.cnbc.com/2019/07/11/these-are-the-stocks-that-have-powered-the-dows-rally-to-27000.html"}, {"symbol": "PFE", "publishedDate": "2019-07-11 15:00:51", "title": "4 Drug Stocks Getting Smashed", "image": "https://cdn.snapi.dev/images/v1/e/x/exv2-2.jpg", "site": "InvestorPlace", "text": "Drug stocks are falling on fears of President Trump's next move on drug prices. Here's a look at the charts.", "url": "https://investorplace.com/2019/07/4-drug-stocks-getting-smashed/"}, {"symbol": "PFE", "publishedDate": "2019-07-11 09:45:31", "title": "Big Pharma Sees Rising Tide in Short Interest", "image": "https://cdn.snapi.dev/images/v1/1/1/11bpha-1.jpg", "site": "24/7 Wall Street", "text": "Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials.", "url": "https://247wallst.com/healthcare-business/2019/07/11/big-pharma-sees-rising-tide-in-short-interest/"}, {"symbol": "PFE", "publishedDate": "2019-07-11 06:35:50", "title": "The 5 Most Shorted Dow Stocks.", "image": "https://cdn.snapi.dev/images/v1/7/s/7shst-1.jpg", "site": "24/7 Wall Street", "text": "It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components.", "url": "https://247wallst.com/investing/2019/07/11/5-most-shorted-dow-stocks-microsoft-on-the-rise/"}, {"symbol": "PFE", "publishedDate": "2019-07-10 13:16:00", "title": "The 10 Biggest Healthcare Stocks", "image": "https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5301712fbusinessman-pointing-to-healthcare-iconsjpgw700opresize.jpg", "site": "The Motley Fool", "text": "How big does a company's market cap need to be to make the top 10 list of healthcare stocks? $111 billion.", "url": "https://www.fool.com/investing/2019/07/10/the-10-biggest-healthcare-stocks.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-07-10 08:19:00", "title": "Here's Why Array BioPharma Soared 75.4% in June", "image": "https://cdn.snapi.dev/images/v1/z/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5305882fprescription-drug-pills-stacked-on-hundred-dollar-bill-gettyjpgw700opresize.jpg", "site": "The Motley Fool", "text": "It looks like Novartis let a big one get away.", "url": "https://www.fool.com/investing/2019/07/10/heres-why-array-biopharma-soared-754-in-june.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-07-10 08:00:14", "title": "Megadeals Enter Biotech Realm \u2014 And 3 Other Trends To Watch In 2019", "image": "https://cdn.snapi.dev/images/v1/c/b/cbm-2.jpg", "site": "Investors Business Daily", "text": "Biotech companies exploded with \"megadeals\" in the first half of 2019 as pharmaceutical companies Bristol-Myers Squibb and AbbVie announced acquisitions worth a combined $137 billion.\r\nThe post Megadeals Enter Biotech Realm \u2014 And 3 Other Trends To Watch In 2019 appeared first on Investor's Business Daily.", "url": "https://www.investors.com/news/technology/biotech-companies-megadeals-political-pressure-china-trends-2019/"}, {"symbol": "PFE", "publishedDate": "2019-07-10 06:35:51", "title": "Merrill Lynch Has 5 Stocks to Buy That Could Beat Q2 Earnings Estimates", "image": "https://cdn.snapi.dev/images/v1/e/t/etf25-30.jpg", "site": "24/7 Wall Street", "text": "The ongoing trade and tariff issues most likely will have the greatest impact when companies report second-quarter earnings.", "url": "https://247wallst.com/investing/2019/07/10/merrill-lynch-has-5-stocks-to-buy-that-could-beat-q2-earnings-estimates/"}, {"symbol": "PFE", "publishedDate": "2019-07-09 16:45:22", "title": "Many Top Pharma & Biotechs Rise As Drug Price Disclosure Thrown Out", "image": "https://cdn.snapi.dev/images/v1/e/t-2/etf14-52.jpg", "site": "24/7 Wall Street", "text": "While the public wants more pharmaceuticals and biotech advancements to treat the endless number of ailments or to extend their lives, there is a simultaneous push to make drugs more affordable.", "url": "https://247wallst.com/healthcare-business/2019/07/09/many-top-pharma-biotechs-rise-as-drug-price-disclosure-thrown-out/"}, {"symbol": "PFE", "publishedDate": "2019-07-08 15:49:16", "title": "Will Sangamo and Pfizer\u2019s Hemophilia Gene Therapy Keep Building Momentum?", "image": "https://cdn.snapi.dev/images/v1/e/m/drugs31.jpg", "site": "24/7 Wall Street", "text": "Sangamo Therapeutics, Inc. (NASDAQ: SGMO) made a handy gain to start out the week after the firm, in conjunction with Pfizer Inc.", "url": "https://247wallst.com/healthcare-business/2019/07/08/will-sangamo-and-pfizers-hemophilia-gene-therapy-keep-building-momentum/"}, {"symbol": "PFE", "publishedDate": "2019-07-08 13:56:11", "title": "Buy Pfizer or Merck?", "image": "https://cdn.snapi.dev/images/v1/p/f/pfi823-1.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions on Pfizer vs. Merck.", "url": "https://www.youtube.com/watch?v=ADrx5gbf-fY&t=111s"}, {"symbol": "PFE", "publishedDate": "2019-07-08 12:59:24", "title": "Trump targets big pharma with new drug price executive order", "image": "https://cdn.snapi.dev/images/v1/g/o/gox9-1.jpg", "site": "Fox Business", "text": "Former Celgene CEO Bob Hugin on President Trump's efforts to rein in drug prices and reform the U.S. health-care system.", "url": "https://www.youtube.com/watch?v=iT1u1-19m5I"}, {"symbol": "PFE", "publishedDate": "2019-07-07 11:17:00", "title": "Better Buy: Pfizer vs. Johnson & Johnson", "image": "https://cdn.snapi.dev/images/v1/9/i/jnj-1.jpg", "site": "The Motley Fool", "text": "Which of these pharmaceutical giants is best positioned to help your portfolio grow?", "url": "https://www.fool.com/investing/2019/07/07/better-buy-pfizer-vs-johnson-johnson.aspx?source=iedfolrf0000001"}, {"symbol": "PFE", "publishedDate": "2019-07-05 20:25:28", "title": "Pfizer Remains A Strong Hold In Our Portfolio", "image": "https://cdn.snapi.dev/images/v1/5/r/drugs12.jpg", "site": "Seeking Alpha", "text": "Shares have had a strong few months.", "url": "https://seekingalpha.com/article/4273635-pfizer-remains-strong-hold-portfolio?source=feed_tag_long_ideas"}, {"symbol": "PFE", "publishedDate": "2019-07-05 20:09:15", "title": "The Top 10 Biotechnology Companies (JNJ, ROG.VX)", "image": "https://cdn.snapi.dev/images/v1/k/t/drugs11.jpg", "site": "Investopedia", "text": "Learn how the marriage of science and technology is changing the world of medicine and creating some of the largest multinational biotechnology corporations.", "url": "https://www.investopedia.com/articles/markets/122215/worlds-top-10-biotechnology-companies-jnj-rogvx.asp"}, {"symbol": "PFE", "publishedDate": "2019-07-05 14:15:22", "title": "The \"Halftime Report\": Can Pfizer hold its gains?", "image": "https://cdn.snapi.dev/images/v1/p/f/pfi882-1.jpg", "site": "CNBC Television", "text": "The \"Halftime Report\" traders answer viewer questions on Pfizer.", "url": "https://www.youtube.com/watch?v=W0ks4lUsGtU&t=155s"}, {"symbol": "PFE", "publishedDate": "2019-07-05 11:49:00", "title": "Trump says administration preparing an executive order on drug prices", "image": "https://cdn.snapi.dev/images/v1/1/0-3/106004366-1562340818732gettyimages-1153940064.jpeg", "site": "CNBC", "text": "\"We're working on it right now a favored nations clause where we pay the lower nation's price is, like Canada,\" President Donald Trump tells reporters.", "url": "https://www.cnbc.com/2019/07/05/trump-administration-preparing-drug-price-executive-order.html"}, {"symbol": "PFE", "publishedDate": "2019-07-03 13:13:01", "title": "Bloomberg Turnaround: How to Take Advantage of a $117 Billion Takeover Bid", "image": "https://cdn.snapi.dev/images/v1/a/s/astra-03-07.jpg", "site": "Bloomberg Markets and Finance", "text": "In 2014, Pfizer Inc. made four attempts to buy AstraZeneca Plc in less than six months. AstraZeneca Chief Executive Officer Pascal Soriot used the situation to galvanize his staff.", "url": "https://www.youtube.com/watch?v=hZzoC8dUw9s"}, {"symbol": "PFE", "publishedDate": "2019-07-03 09:34:00", "title": "Will the Pharma Space Witness More Mega-Merger Deals in 2H?", "image": "https://cdn.snapi.dev/images/v1/3/8/385.jpg", "site": "Zacks Investment Research", "text": "After two mega-mergers, Bristol-Myers/Celgene and AbbVie/Allergan, in first half of 2019, it remains to be seen if more such deals are in store for the second half.", "url": "https://www.zacks.com/stock/news/437588/will-the-pharma-space-witness-more-mega-merger-deals-in-2h"}, {"symbol": "PFE", "publishedDate": "2019-07-03 07:58:31", "title": "3 Big Stock Charts for Wednesday: CVS Health, Pfizer and Weyerhaeuser", "image": "https://cdn.snapi.dev/images/v1/e/t/etf27-36.jpg", "site": "InvestorPlace", "text": "The stock charts of CVS Health, Pfizer and Weyerhaeuser head into the midpoint of the week on the verge of major moves.", "url": "https://investorplace.com/2019/07/3-big-stock-charts-for-wednesday-cvs-pfe-wy/"}, {"symbol": "PFE", "publishedDate": "2019-07-02 16:56:00", "title": "Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis", "image": "https://cdn.snapi.dev/images/v1/g/a/drugs47.jpg", "site": "Zacks Investment Research", "text": "Pfizer's (PFE) Eucrisa ointment is found safe in a late-stage label expansion study for treating mild to moderate atopic dermatitis in minors aged 3 months to 2 years.", "url": "https://www.zacks.com/stock/news/437327/pfizers-eucrisa-proves-safety-in-kids-with-atopic-dermatitis"}, {"symbol": "PFE", "publishedDate": "2019-07-02 15:38:28", "title": "3 Dow Jones Stocks to Buy for the Second Half", "image": "https://cdn.snapi.dev/images/v1/e/t/etf35-47.jpg", "site": "InvestorPlace", "text": "As we head into the second half of the year, here are three Dow Jones stocks to buy for a long-term portfolio.", "url": "https://investorplace.com/2019/07/3-dow-jones-stocks-to-buy-for-the-second-half/"}, {"symbol": "PFE", "publishedDate": "2019-07-02 15:04:26", "title": "Ex-FDA Chief Scott Gottlieb Defends Return To Private Sector, Warren Calls For Resignation", "image": "https://cdn.snapi.dev/images/v1/1/1/11-5.jpg", "site": "Benzinga", "text": "It didn't take long for ex-FDA Commissioner Scott Gottlieb to land a new gig: he joined Pfizer Inc.'s board of directors and signed on as a partner at the venture capital firm NEA.", "url": "https://www.benzinga.com/news/19/07/14020031/ex-fda-chief-scott-gottlieb-defends-return-to-private-sector-warren-calls-for-resignation"}, {"symbol": "PFE", "publishedDate": "2019-07-02 10:06:00", "title": "Warren calls on ex-FDA chief Gottlieb to resign from Pfizer board, says it 'smacks of corruption'", "image": "https://cdn.snapi.dev/images/v1/f/u/105830370-1554293317973gettyimages-1134332168.jpeg", "site": "CNBC", "text": "'This kind of revolving door influence-peddling smacks of corruption, and makes the American people rightly cynical and distrustful,' Warren said in a July 1 letter to Gottlieb.", "url": "https://www.cnbc.com/2019/07/02/sen-warren-calls-on-ex-fda-chief-gottlieb-to-resign-from-pfizer-board.html"}, {"symbol": "PFE", "publishedDate": "2019-07-02 10:03:35", "title": "Scott Gottlieb defends his decision to join Pfizer's board", "image": "https://cdn.snapi.dev/images/v1/p/f/pfi923.jpg", "site": "CNBC Television", "text": "Former FDA Commissioner Scott Gottlieb was recently elected to the board of Pfizer.", "url": "https://www.youtube.com/watch?v=nFERazuvc3k"}, {"symbol": "PFE", "publishedDate": "2019-07-02 09:43:15", "title": "Scott Gottlieb on joining Pfizer's board, drug prices, and 'Medicare for All'", "image": "https://cdn.snapi.dev/images/v1/w/n/scott-gottlieb-on-joining-pfizers-board-drug-prices-and-medicare-for-all.jpg", "site": "CNBC Television", "text": "Former FDA Commissioner Scott Gottlieb was recently elected to the board of Pfizer.", "url": "https://www.youtube.com/watch?v=gGqaYXJZJ4E"}, {"symbol": "PFE", "publishedDate": "2019-07-02 09:15:00", "title": "Former FDA Commissioner Gottlieb defends decision to join Pfizer board", "image": "https://cdn.snapi.dev/images/v1/7/k/105050631-gettyimages-866274606.jpg", "site": "CNBC", "text": "Pfizer last week announced Gottlieb would join its board of directors \u2014 a job that paid a minimum of $335,000 in stock and cash in 2018.", "url": "https://www.cnbc.com/2019/07/02/former-fda-commissioner-gottlieb-defends-decision-to-join-pfizer-board.html"}, {"symbol": "PFE", "publishedDate": "2019-07-01 10:00:12", "title": "How Pfizer Is Looking to Expand Its Eczema Treatment", "image": "https://cdn.snapi.dev/images/v1/i/j/pfi9.jpg", "site": "24/7 Wall Street", "text": "Pfizer Inc. (NYSE: PFE) has announced topline results from its most recent late-stage study in children aged 3 months to less than 24 months with mild to moderate atopic dermatitis (AD), also known as eczema, a chronic skin disease characterized by inflammation of the skin and skin barrier defects.", "url": "https://247wallst.com/healthcare-business/2019/07/01/how-pfizer-is-looking-to-expand-its-eczema-treatment/"}, {"symbol": "PFE", "publishedDate": "2019-07-01 09:43:00", "title": "Pfizer's (PFE) Avastin Biosimilar Zirabev Gets FDA Approval", "image": "https://cdn.snapi.dev/images/v1/f/c/drugs23.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) gets FDA approval for biosimilar Avastin, Zirabev. This is Pfizer's second oncology biosimilar to be approved in United States.", "url": "https://www.zacks.com/stock/news/436385/pfizers-pfe-avastin-biosimilar-zirabev-gets-fda-approval"}, {"symbol": "PFE", "publishedDate": "2019-07-01 09:21:00", "title": "Pfizer's DMD Gene Therapy Shows Severe Side Effects in Study", "image": "https://cdn.snapi.dev/images/v1/3/7/drugs25.jpg", "site": "Zacks Investment Research", "text": "Pfizer (PFE) presents early data from a study on its investigational gene therapy for DMD. However, the study highlighted some serious side effects in two out of the six participants.", "url": "https://www.zacks.com/stock/news/436331/pfizers-dmd-gene-therapy-shows-severe-side-effects-in-study"}, {"symbol": "PFE", "publishedDate": "2019-07-01 08:27:10", "title": "Pfizer stock up 1.2% premarket after drugmaker announces positive results from Phase 4 eczema study", "image": "https://cdn.snapi.dev/images/v1/w/g/drugs19.jpg", "site": "Market Watch", "text": "Shares of Pfizer Inc. PFE, -0.25% ticked up 1.2% in premarket trade Monday after the drugmaker said a Phase 4 study showed that an eczema treatment was well-tolerated in babies between 3 months and two years of age when used over a period of four weeks.", "url": "https://www.marketwatch.com/story/pfizer-stock-up-12-premarket-after-drugmaker-announces-positive-results-from-phase-4-eczema-study-2019-07-01"}, {"symbol": "PFE", "publishedDate": "2019-07-01 06:38:04", "title": "Acquisition Improves the Outlook of Pfizer Stock", "image": "https://cdn.snapi.dev/images/v1/a/c/drugs17.jpg", "site": "InvestorPlace", "text": "Array's cancer drug pipeline, which has many advanced, high-potential treatments, can boost Pfizer stock price over the long-term.", "url": "https://investorplace.com/2019/07/acquiring-array-biopharma-improves-pfizers-prospects/"}]